Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients

Diabetes, Obesity and Metabolism

Volumn 8, Issue 5, 2006, Pages 555-560

  Alvarez Castro, P ^a   Isidro, M L ^a   Garcia Buela J ^a   Dieguez, C ^b   Casanueva, F F ^b   Cordido, Fernando ^a,c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Ghrelin; Insulin; Obesity

Indexed keywords

GHRELIN; GLUCOSE; GLUCOSE OXIDASE; GROWTH HORMONE RELEASING FACTOR; INSULIN; PLACEBO;

ACUTE DRUG ADMINISTRATION; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INCREASED APPETITE; INSULIN BLOOD LEVEL; OBESITY; RANK SUM TEST;

EID: 33746925966     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00551.x     Document Type: Article

References (52)

1. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998; 19: 717-797.
2. Dieguez C, Casanueva FF. Ghrelin: A step forward in the understanding of somatotroph cell function and growth regulation. Eur J Endocrinol 2000; 142: 913-917.
3. Kojima M, Hosoda H, Data Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Science 1999; 402: 656-658.
4. Howard HD, Feighner SD, Cully DF et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-976.
5. Cowley MA, Smith RG, Diano S et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003; 37: 649-661.
6. Caminos JE, Nogueiras R, Blanco M et al. Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland. Endocrinology 2003; 144: 5089-5097.
7. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25: 426-457.
8. Ghigo E, Arvat E, Giordano R et al. Biologic activities of growth hormone secretagogues in humans. Endocrine 2001; 14: 87-93.
9. Zhang W, Chen M, Chen X, Segura BJ, Mulholland MW. Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol 2001; 537: 231-236.
10. Gaytan F, Barreiro ML, Chopin LK et al. Immuno-localization of ghrelin and its functional receptor, the type 1A growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab 2003; 88: 879-887.
11. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur J Pharmacol 2002; 440: 235-254.
12. Arvat E, Maccario M, Di Vito L et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001; 86: 1169-1174.
13. Sibilia V, Pagani F, Guidobono F et al. Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats. Neuroendocrinology 2002; 75: 92-97.
14. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-909.
15. Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
16. Shuto Y, Shibasaki T, Otagiri A et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding and adiposity. J Clin Invest 2002; 109: 1429-1436.
17. Broglio F, Benso A, Gottero C et al. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest 2003; 26: 192-196.
18. Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001; 12: 118-122.
19. Casoni P, Papotti M, Ghe C et al. Identification, characterization and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 2001; 86: 1738-1745.
20. Bedendi I, Alloatti G, Marcantoni A et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghelin and des-Gln14-ghrelin. Eur J Pharmacol 2003; 476: 87-95.
21. Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001; 104: 1430-1435.
22. Cummings DE, Foster KE. Ghrelin-leptin tango in body-weight regulation. Gastroenterology 2003; 124: 1532-1535.
23. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146: 241-244.
24. Date Y, Nakazato M, Hashiguchi S et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-129.
25. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143: 185-190.
26. Adeghate E, Ponery AS. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 2002; 14: 555-560.
27. Broglio F, Arvat E, Benso A et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-5086.
28. Broglio F, Benso A, Castiglioni C et al. The endocrine response to ghrelin as a function of gender in human young and elderly subjects. J Clin Endocrinol Metab 2003; 88: 1537-1542.
29. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab 2003; 88: 701-704.
30. Akamizu T, Takaya K, Irako T et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol 2004; 150: 447-455.
31. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5998.
32. Shiiya T, Nakazato M, Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
33. Haqq AM, Farooqi IS, O'Rahilly S et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 2003; 88: 174-178.
34. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JPH. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 2002; 87: 2984-2987.
35. Cummings DE, Schwartz MW. Genetis and pathophysiology of human obesity. Annu Rev Med 2003; 4: 453-471.
36. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719.
37. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin are decreased in human obesity. Diabetes 2001; 50: 707-709.
38. Saad MF, Bernaba B, Hwu C et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 2002; 87: 397-400.
39. Caixas A, Bashore C, Nash W, Pi-Sunyer X, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 2002; 87: 1902-1905.
40. Lucidi P, Murdolo G, Di Loreto G et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes 2002; 51: 2911-2914.
41. Volante M, Allia E, Gugliotta P et al. Expression of ghrelin and the GH secretagogue receptor by the pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300-1308.
42. Wierup N, Svensson H, Sundler F. The ghrelin cell: A novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
43. Broglio F, Gottero C, Benso A et al. Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans. J Clin Endocrinol Metab 2003; 88: 4268-4272.
44. Tassone F, Broglio F, Destefanis S et al. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 2003; 88: 5478-5483.
45. Gauna C, Meyler FM, Janssen J et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacetylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 5035-5042.
46. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003; 144: 916-921.
47. Kanaley JA, Weatherup-Dentes MM, Jaynes EB, Hartman ML. Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab 1999; 84: 3156-3161.
48. Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores GH responsiveness to GH-releasing hormone administration in obese subjects. J Clin Endocrinol Metab 1989; 68: 290-293.
49. Furuhata Y, Kagaya R, Hirabayashi K et al. Development of obesity in transgenic rats with low circulating growth hormone levels: Involvement of leptin resistance. Eur J Endocrinol 2000; 143: 535-541.
50. Cordido F, Fernandez T, Martinez T, PeinóR, Dieguez C, Casanueva F. Effect of acute pharmacological reduction of plasma free fatty acids on GHRH-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 1998; 83: 4350-4354.
51. Cordido F, Peñalva A, Peino R, Casanueva F, Dieguez C. Effect of the combined administration of Growth Hormone (GH)-releasing hormone, GH-releasing peptide-6 and pyridostigmine in normal and obese subjects. Metabolism 1995; 44: 745-748.
52. Alvarez P, Isidro L, Garcia-Buela J et al. Marked GH secretion after ghrelin administration alone or combined with growth hormone-releasing hormone (GHRH) in obese patients. Clin Endocrinol 2004; 61: 250-255.